Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Drug Delivery | Whitepapers & Reports

Celanese Announces Agreement with Glaukos Corporation for Sustained Release Glaucoma Treatment

25 May 2023
Celanese to Supply VitalDose® Drug Delivery Platform for Glaukos’ Investigational iDose® TR Intraocular Implant.
Open document in a new tab

Related Resources

Novel Nanorobots Pave the Way for Cancer Treatment

A preclinical study conducted by a team of scientists at the Institute for Bioengineering of Catalonia highlights the therapeutic potential of nanorobots in bladder cancer treatment.
Read More

Sangamo Therapeutics Engineers a State-Of-The-Art Capsid, Revolutionising Drug Delivery

Sangamo Therapeutics developed a novel capsid that achieved outstanding results in a preclinical study, this could have significant implications for treating neurological disorders.
Read More

Related Online Activities

Join the conversation with our upcoming Monthly Science Exchanges and Webinars:
18/04/24
RNA Delivery Beyond The Liver
02/05/24
Inhaled Biologics Formulation